InvestorsHub Logo
Followers 29
Posts 2139
Boards Moderated 0
Alias Born 05/03/2020

Re: None

Sunday, 03/07/2021 1:05:39 PM

Sunday, March 07, 2021 1:05:39 PM

Post# of 233004
Here's what we know: (You can disagree or not)

In the bag:
1. HIV PE SS and BLA resubmit off of the RTF received last year, Dr. Rahman to bring it across the finish line.
2. 24% mortality rate on critical patients over all the current drugs used in SOC (dexamethasone, remdes, *mab, co-plasma and the like). Real numbers with real p values.
3. 140 patience CD12 trial extension with PE on hospital stay. CYDY destroyed that with 166% rate versus SOC.


May be in the bag:
1. LH quick trial and interim looks.
2. Next steps on NASH, TNBC current trials and interim looks.

Wildcards:
1. Brazil EUA
2. Canada IO
3. MHRA, EMA EUA
4. Janet Woodcocks' statement regarding we're in a pandemic situation and FDA's p-value.
5. Philippines nod as it's dependent upon approval from any country (thanks for that info Maverick0408)


In the bag options will take time but the beauty of it is, they are 'in the bag'. Wildcards are just that, wildcards, they can literally happen any moment. This is now a waiting game, something WILL matriculate. Don't get caught up in the FUD.

GLTU/A.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News